Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Interest Expenses (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Interest Expenses for 6 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 46.47% to $1.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.0 million, a 128.77% increase, with the full-year FY2025 number at $6.0 million, up 128.77% from a year prior.
  • Interest Expenses was $1.9 million for Q4 2025 at Orthopediatrics, up from $1.8 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.9 million in Q4 2025 to a low of $21000.0 in Q3 2023.
  • A 3-year average of $893200.0 and a median of $876500.0 in 2024 define the central range for Interest Expenses.
  • Biggest YoY gain for Interest Expenses was 1823.81% in 2024; the steepest drop was 11.22% in 2024.
  • Orthopediatrics' Interest Expenses stood at $21000.0 in 2023, then soared by 6180.95% to $1.3 million in 2024, then surged by 46.47% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Interest Expenses are $1.9 million (Q4 2025), $1.8 million (Q3 2025), and $1.1 million (Q2 2025).